O
11.40
0.08 (0.71%)
市场趋势
短期 | 中期 | ||
行业 | Biotechnology (US) | 混合的 | 混合的 |
Biotechnology (全球的) | 混合的 | 混合的 | |
股票 | Oric Pharmaceuticals, Inc. | 看涨 | 看跌 |
AIStockmoo 评分
-0.3
分析师共识 | 4.0 |
内部交易活动 | -3.0 |
价格波动 | -4.5 |
技术平均移动指标 | 0.0 |
技术振荡指标 | 2.0 |
平均 | -0.30 |
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer. |
|
部门 | Healthcare |
行业 | Biotechnology |
投资方式 | Small Value |
内部持股比例 | 7.93% |
机构持股比例 | 102.70% |
所有权
姓名 | 日期 | 持有股份 |
---|---|---|
Nextech Invest, Ltd. | 30 Jun 2025 | 7,162,637 |
Nextech Invest Ltd. | 31 Dec 2024 | 5,285,714 |
Sr One Capital Management, Lp | 30 Jun 2025 | 4,514,929 |
First Turn Management, Llc | 30 Jun 2025 | 2,009,923 |
52周波幅 | ||
目标价格波幅 | ||
高 | 19.00 (HC Wainwright & Co., 66.67%) | 购买 |
中 | 17.50 (53.51%) | |
低 | 15.00 (Ladenburg Thalmann, 31.58%) | 购买 |
平均值 | 17.25 (51.32%) | |
总计 | 4 购买 | |
平均价格@调整类型 | 10.27 |
公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
---|---|---|---|---|
Guggenheim | 04 Sep 2025 | 18.00 (57.89%) | 购买 | 10.77 |
13 Aug 2025 | 18.00 (57.89%) | 购买 | 9.83 | |
HC Wainwright & Co. | 14 Aug 2025 | 19.00 (66.67%) | 购买 | 9.93 |
JP Morgan | 14 Aug 2025 | 17.00 (49.12%) | 购买 | 9.93 |
Ladenburg Thalmann | 08 Jul 2025 | 15.00 (31.58%) | 购买 | 10.43 |
名称 | 平均购买 ($) | 平均卖出 ($) | 总净额 | 总净值 ($) |
---|---|---|---|---|
CHACKO JACOB | - | 10.82 | -125,000 | -1,352,500 |
累积净数量 | -125,000 | |||
累积净值 ($) | -1,352,500 | |||
累积平均购买 ($) | - | |||
累积平均卖出 ($) | 10.82 |
名称 | 持有人 | 日期 | 类型 | 数量 | 价格 | 价值 ($) |
---|---|---|---|---|---|---|
CHACKO JACOB | 职员 | 22 Sep 2025 | 自动卖出 (-) | 125,000 | 10.82 | 1,352,500 |
支撑、阻力和趋势线水平是由人工智能(AI)模型生成的,请谨慎解读。
投资组合